Joinn Laboratories(China)Co.,Ltd.
SHH: 603127.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Yuxia Feng
- Employees
- 2,510
- Headquarters
- Beijing, China
- IPO year
- 2017
- Market cap
- CN¥28.9B
- Website
- https://www.joinn-lab.com
Loading 603127…
Loading profile data…Frequently asked questions about 603127
What does Joinn Laboratories(China)Co.,Ltd. (603127.SS) do?
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug saf...
Where does 603127.SS trade?
Joinn Laboratories(China)Co.,Ltd. (603127.SS) trades on the Shanghai Stock Exchange.
What sector is 603127.SS in?
Joinn Laboratories(China)Co.,Ltd. (603127.SS) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Joinn Laboratories(China)Co.,Ltd.?
Yuxia Feng is the chief executive officer of Joinn Laboratories(China)Co.,Ltd. (603127.SS).
Where is Joinn Laboratories(China)Co.,Ltd. headquartered?
Joinn Laboratories(China)Co.,Ltd. is headquartered in China.
Does 603127.SS pay a dividend?
Yes — Joinn Laboratories(China)Co.,Ltd. (603127.SS) paid a trailing twelve-month dividend of CNY 0.03 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603127.SS go public?
Joinn Laboratories(China)Co.,Ltd. (603127.SS) completed its initial public offering in 2017.